NewcelX NCEL
NASDAQ NCEL
$3.29 -0.08 (-2.42%)
As of: Aug 21, 2026 · 10:31 AM EDT

NewcelX (NCEL) Short term Debt (2019 - 2025)

NewcelX (NCEL) posted quarterly Short term Debt of $355000.0 for Q4 2025, up 21.16% year-over-year from $293000.0 in Q4 2024, and up 21.16% quarter-over-quarter from $293000.0 in Q4 2024.

NewcelX (NCEL) Short term Debt (2019 - 2025) Analysis & Trends

NewcelX (NCEL) has reported Short term Debt for 6 consecutive years, with $355000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Short term Debt rose 21.16% year-over-year to $355000.0; the TTM figure through Dec 2025 stood at $355000.0 (up 21.16% YoY), while the FY2025 annual figure was $355000.0, up 21.16% from the prior year.
  • Short term Debt improved to $355000.0 in Q4 2025 per NCEL's latest filing, from $293000.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $355000.0 in Q4 2025 and bottomed at $292000.0 in Q4 2022.
  • Historically, Short term Debt has averaged $312666.7 across 4 years, with a median of $309000.0 in 2023.
  • Annual changes were most pronounced in 2024 — Short term Debt retreated 2.66% — and 2025, when it climbed 21.16%.
  • NewcelX's Short term Debt stood at $292000.0 in 2022, then climbed by 3.08% to $301000.0 in 2023, then retreated by 2.66% to $293000.0 in 2024, then grew by 21.16% to $355000.0 in 2025.
  • Business Quant data shows NCEL's Short term Debt at $355000.0 in Q4 2025, $293000.0 in Q4 2024, and $317000.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 140.23 Bn 132.38 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.97 Bn 78.97 Bn 3.93 Bn
3 Argenx Se 65.29 Bn 60.11 Bn 1.37 Bn
4 Moderna 59.88 Bn 54.74 Bn 52.00 Mn
5 BeOne Medicines 42.20 Bn 37.11 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.62 Bn 28.31 Bn 992.69 Mn
7 BioNTech SE 28.69 Bn 10.30 Bn 668.28 Mn
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn
9 Royalty Pharma 27.16 Bn 26.33 Bn -
10 NewcelX 12.65 Mn 10.45 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 355,000.00
Dec 31, 2024 293,000.00
Jun 30, 2024 317,000.00
Dec 31, 2023 301,000.00
Jun 30, 2023 318,000.00
Dec 31, 2022 292,000.00
Dec 31, 2020 463,980.00
Dec 31, 2019 150,000.00